Researchers at a laboratory in Vancouver are looking to possibly cure Crohn’s diseases based on the incredible recovery made by one of their patients.
It all started when a patient at the InspireHealth care center suffering from pancreatic cancer started getting worse. He eventually came down with an infection, but surprisingly, his tumors also shrank. Further examinations found that this had happened with other two patients in similar conditions.
Crohn’s disease is a type of inflammatory bowel disease (IBD) that can cause serious problems, including severe abdominal pain, diarrhea and bloating. Currently, there is no cure and those suffering usually need to take immune-suppressing medications throughout their lives, leaving them open to a series of possible side effects.
Dr. Hal Gunn, the founder of biotech company Qu Biologics working on this treatment, is conducting a series of trials at the moment, which so far look very promising. QBECO, the therapy being developed now, “appears to be safe and well-tolerated” and at the same time “associated with consistently positive trends in response, improvement and remission throughout the treatment period of the trial, establishing proof-of-concept in the treatment of participants with Crohn’s disease”.
The drug comes in the form of an injection and can be self-administered every two days, making it particularly simple to use and practical.
Even though the first clinical test displayed impressive Clinical remission rates after 8 weeks of treatment “of 50%, more than double the placebo rate of 23% (p=0.16)”, doctors are cautioning patients that the procedure still has a long way to go before it can make it on the market.
This moment can mark an important step towards finding better solutions to manage and treat a number of cancers.